ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
06/01/2026
Back to search
Official data from USPTO
RISKGUARD HEREDITARY CANCER TEST
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
06/02/2026
Classification
Registered
Trademark type
Combined
Nice classes
10, 44
Filing date
11/22/2024
Registration date
11/04/2025
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/04/2025
Last transaction
06/02/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
03/06/2024
First use in commerce
03/06/2024
Drawing code
5
Owner type
03
Owner location
Madison, WI, US
Examiner
STANWOOD, STEPHEN D
Law office
M60
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the stylized mark "RISKGUARD HEREDITARY CANCER TEST", stacked.
Holders and representatives
Holders
E. C. (pessoa física)
Representatives
Sana Hakim K&L Gates LLP
Technical classification
Nice Classes
Class 10Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 10
Diagnostic apparatus for the detection of cancer by detecting genes for hereditary canceridentifying hereditary risk associated with cancer and identifying predisposition to cancer; Apparatus for collecting biological samplesblood or salivafor use in the detection of cancer and pre-cancer for medical purposes by detecting genes for hereditary canceridentifying hereditary risk associated with cancer and identifying predisposition to cancer; Saliva collection devices and blood collecting tubes for use in the detection of cancer and pre-cancer for medical purposes by detecting genes for hereditary canceridentifying hereditary risk associated with cancer and identifying predisposition to cancer
Class 44
Medical testing servicesgenetic testing and next generation sequencing test for diagnosis and treatment of cancer featuring detection of genes for hereditary canceridentification of hereditary risk associated with cancer and identification of predisposition to cancer
Publications
History of USPTO decisions and trademark events.
27 publications found
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
04/16/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/04/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
11/04/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/16/2025
PUBO
PUBLISHED FOR OPPOSITION
09/16/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/10/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/13/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
08/13/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/13/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
08/13/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/13/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/05/2025
GNRT
NON-FINAL ACTION E-MAILED
08/05/2025
CNRT
NON-FINAL ACTION WRITTEN
08/05/2025
IUAA
USE AMENDMENT ACCEPTED
08/05/2025
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
08/04/2025
DOCK
ASSIGNED TO EXAMINER
07/30/2025
DPCC
DIVISIONAL PROCESSING COMPLETE
07/30/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/23/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/10/2025
ALIE
ASSIGNED TO LIE
01/31/2025
IUAF
USE AMENDMENT FILED
01/29/2025
DRRR
DIVISIONAL REQUEST RECEIVED
01/29/2025
EAAU
TEAS AMENDMENT OF USE RECEIVED
01/29/2025
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
01/29/2025
NWAP
NEW APPLICATION ENTERED
11/22/2024
Continuous trademark protection
Get notified about every new filing that threatens RISKGUARD HEREDITARY CANCER TEST or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.